Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
How do you approach treatment selection in patients with rheumatoid arthritis and severe COPD?
Related Questions
Do you avoid tocilizumab in patients with prior bariatric surgery given the risk of GI perforation?
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
How would you approach rheumatoid arthritis treatment for widespread large rheumatoid nodules but no active synovitis or subjective joint pain?
Do you combine methotrexate and leflunomide for the treatment of RA?
Do you avoid the use of TNF inhibitors in patients with RA-ILD?
Would you add abatacept to treat active inflammatory arthritis in a patient with history of RA-ILD who is already taking mycophenolate?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How would you approach a patient with anti-scl70 ab positive sine scleroderma complicated by ILD who also has seropositive RA with active arthritis?
When considering biologic therapy after failure of MTX or triple therapy, do you consider using Abatacept as a first line biologic?
